Item 5. Other Information
Item
5. Other Information
None.
28
Item
6. Exhibits
Exhibit
Description
3.1
Sixth
Amended and Restated Certificate of Incorporation, dated June 30, 2023 (incorporated by reference to Exhibit 3.1 of our Current Report
on Form 8-K filed on July 5, 2023).
4.1
Representative’s
Warrant (incorporated by reference to Exhibit 4.1 of our Current Report on Form 8-K filed on July 5, 2023).
10.1
Underwriting
Agreement, dated June 29, 2023 (incorporated by reference to Exhibit 10.1 of our Current Report on Form 8-K filed on July 5, 2023).
10.2
Employment
Agreement, dated June 20, 2023, between the Company and John Wesolowski (incorporated by reference to Exhibit 10.15 of our Form S-1
filed on June 23, 2023).
31.1*
Certification
of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*
Certification
of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant
to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*
Certification
of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
32.2*
Certification
of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
101.INS
Inline
XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded
within the Inline XBRL document.
101.SCH
Inline
XBRL Taxonomy Extension Schema Document
101.CAL
Inline
XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF
Inline
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB
Inline
XBRL Taxonomy Extension Label Linkbase Document
101.PRE
Inline
XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover
Page Interactive Data File (embedded within the Inline XBRL document)
* Filed
herewith.
29
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
INTENSITY
THERAPEUTICS, INC.
By:
/s/
Lewis H. Bender
Lewis
H. Bender
President
and Chief Executive Officer
(principal
executive officer)
Date:
August 14, 2023
By:
/s/
John Wesolowski
John
Wesolowski
Interim
Chief Financial Officer, Principal Accounting Officer and Controller
(principal
financial and accounting officer)
Date:
August 14, 2023
30
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.